national institute of health

A new study has warned that declining childhood vaccination rates in the United States could trigger a dramatic resurgence of diseases that were eradicated years ago. What Happened: On Sunday, former U.S. Food and Drug Administration (FDA) Commissioner Scott Gottlieb shared a study on X...

Formal conclusions from the NIH-funded trial of COVID-19 Convalescent Plasma in Outpatients (C3PO) demonstrate that COVID-19 convalescent plasma did not prevent disease progression in a high-risk group of outpatients.  The final results from the trial were published in the New...

"Age is just a number, not a state of mind or a reason for any type of particular behavior." -Cecelia Ahern Alzheimer's disease is the sixth leading cause of death in the U.S., although recent estimates indicate it may now be the third most common cause of death, behind heart disease...

Congressional Republicans and Democrats joined forces on Thursday to pass the 21st Century Cures Act, a comprehensive piece of healthcare legislation that provides funding for researching some of America’s biggest health concerns. Senate Vote 94–5 The legislation passed a Senate vote 94...

Last Tuesday, Heat Biologics Inc (NASDAQ: HTBX) announced its collaboration with the University of Miami to research a Zika virus vaccine. The research will implement the existing gp96 platform. Essentially, gp96 is a molecule present in all human cells, which interacts with proteins to trigger an...

HC Wainwright has initiated coverage of Proteon Therapeutics Inc (NASDAQ: PRTO) with a Buy rating and a price target of $18, representing a potential return of 105 percent. Proteon is developing a novel therapy to help prolong vascular access patency for dialysis patients. The company's lead...